Siemens resumes oncology shipments
The Oncology Care Systems division of Siemens Medical Systemshas received Food and Drug Administration clearance to resumeshipping and manufacturing in the U.S., the vendor reported lastweek. Siemens halted domestic shipments from the Concord,
The Oncology Care Systems division of Siemens Medical Systemshas received Food and Drug Administration clearance to resumeshipping and manufacturing in the U.S., the vendor reported lastweek. Siemens halted domestic shipments from the Concord, CA,facility last year after FDA audits uncovered problems in manufacturingprocesses at the plant (SCAN 10/12/94).
Siemens received FDA approval on Nov. 2 to resume U.S. shipping,and got the agency's go-ahead in October to manufacture for U.S.customers. The facility has been shipping and manufacturing forinternational customers since March, the company reported. Theplant makes radiation oncology treatment and verification products.
Mammography Study Compares False Positives Between AI and Radiologists in DBT Screening
May 8th 2025For DBT breast cancer screening, 47 percent of radiologist-only flagged false positives involved mass presentations whereas 40 percent of AI-only flagged false positive cases involved benign calcifications, according to research presented at the recent American Roentgen Ray Society (ARRS) conference.
